Literature DB >> 31809724

Challenges With Stopping Long-term Nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B.

K Seng Liem1, Adam J Gehring2, Jordan J Feld3, Harry L A Janssen2.   

Abstract

Entities:  

Year:  2019        PMID： 31809724     DOI： 10.1053/j.gastro.2019.10.050

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  9 in total

1.  Virus reactivation in a non-cirrhotic HBV patient requiring liver transplantation after cessation of nucleoside analogue therapy.

Authors:  Han Zhang; Fang Chen; Erick Giang; Fei Bao; Georg M Lauer; Christopher Marsh; Mansun Law; Paul J Pockros
Journal:  Antivir Ther       Date:  2021-09-26       Impact factor: 1.679

2.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2022-04-01

Review 3.  Clinical management of chronic hepatitis B: A concise overview.

Authors:  Arno Furquim d'Almeida; Erwin Ho; Stijn Van Hees; Thomas Vanwolleghem
Journal:  United European Gastroenterol J       Date:  2021-11-30       Impact factor: 4.623

Review 4.  Aiming for Functional Cure With Established and Novel Therapies for Chronic Hepatitis B.

Authors:  Hannah S J Choi; Alexander Tonthat; Harry L A Janssen; Norah A Terrault
Journal:  Hepatol Commun       Date:  2021-12-10

5.  The Human Male Liver Is Predisposed to Inflammation Via Enhanced Myeloid Responses to Inflammatory Triggers.

Authors:  Adrian Kuipery; Deeqa Mahamed; Shirin Nkongolo; June Ann D'Angelo; Alexandra Johnson Valiente; Aman Mehrotra; William C Chapman; Peter Horton; Ian McGilvray; Harry L A Janssen; Adam J Gehring
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

Review 6.  Virological Treatment Monitoring for Chronic Hepatitis B.

Authors:  Elisabetta Loggi; Stefano Gitto; Filippo Gabrielli; Elena Franchi; Hajrie Seferi; Carmela Cursaro; Pietro Andreone
Journal:  Viruses       Date:  2022-06-24       Impact factor: 5.818

Review 7.  Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection.

Authors:  Ruben C Hoogeveen; André Boonstra
Journal:  Front Immunol       Date:  2020-03-04       Impact factor: 7.561

8.  Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy.

Authors:  Stephan Ehrhardt; Chloe Lynne Thio; Marieke Bierhoff; Kenrad E Nelson; Nan Guo; Yuanxi Jia; Chaisiri Angkurawaranon; Podjanee Jittamala; Verena Carrara; Wanitda Watthanaworawit; Clare Ling; Fuanglada Tongprasert; Michele van Vugt; Marcus Rijken; Francois Nosten; Rose McGready
Journal:  BMJ Open       Date:  2020-09-13       Impact factor: 2.692

Review 9.  Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas.

Authors:  Yu-Chan Yang; Hung-Chih Yang
Journal:  Viruses       Date:  2021-12-21       Impact factor: 5.048
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.